Counterfeit medicines pose a danger to patients. With its NFC labels, Schreiner MediPharm has developed a secure digital solution that offers optimised counterfeit and tamper evidence and enables interactive patient support. Using a smartphone, users can quickly and reliably check whether they are holding an original product in their hands.
The trend towards self-medication with pens and autoinjectors is increasing. While traditional sealing solutions and open authentication features already offer patients a certain degree of protection against possible counterfeiting, digital features significantly increase security. Schreiner MediPharms NFC labels have integrated chips with an encryption function, whose codes cannot be falsified or manipulated. The end user must simply hold their smartphone up to the NFC label, to check the authenticity of the product in a matter of seconds.
First opening indication and protection against grey market activities
Thanks to its special design, the NFC label encloses part of the cap of the pen or autoinjector and thus enables digital authentication as well as an irreversible digital sealing function. When scanned with a smartphone, the system automatically checks whether the product is intact or has already been opened. In addition to increased product security, the NFC technology enables also the tracking of grey market activities. Pharmaceutical manufacturers can thus check their supply chain and patients receive additional safety when using their medication.
Easy to integrate into existing manufacturing processes
Thanks to a particularly robust label design that protects the integrated chip from mechanical stress and possible functional failures, the NFC labels can be easily integrated into pharmaceutical production. The label can even be reliably dispensed on high-speed systems. The NFC functionality is fully retained, enabling reliable reading of the chip data throughout the entire product life cycle.
Source: Schreiner MediPharm
